Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Big Pharma Touts US Investments Amid Tariff Threat No Photo Available

Yeji Jesse Lee

As tariffs loom on the horizon, Big Pharma companies laud their plans to ramp up U.S. manufacturing — even as they're set to eat costs... (more story)

FDA Drug Rules Under Fire in Pharma Free Speech Fight No Photo Available

Hannah Albarazi

Vanda Pharmaceuticals says it spent years establishing that one of its flagship, FDA-approved products is an effective and safe treatm... (more story)

Legislation Roundup: States Consider Slew Of Abortion Bills No Photo Available

Mark Payne

Nearly three years after the U.S. Supreme Court's Dobbs decision upended federal abortion access protection, dozens of abortion-relate... (more story)